- Home
- LOMA vs PLSE Comparison
LOMA vs PLSE Comparison
Compare LOMA & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOMA | PLSE |
|---|---|---|
| Founded | 1926 | 2014 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LOMA | PLSE |
|---|---|---|
| Price | $11.09 | $22.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $15.00 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 319.8K | 217.2K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.53 | $840.00 |
| Revenue Next Year | N/A | $287.54 |
| P/E Ratio | $187.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.04 | $12.56 |
| 52 Week High | $14.17 | $26.30 |
Technical Indicators
Market Signals| Indicator | LOMA | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 48.37 | 55.70 |
| Support Level | $10.56 | $13.62 |
| Resistance Level | $12.26 | $23.42 |
| Average True Range (ATR) | 0.46 | 1.53 |
| MACD | -0.05 | 0.33 |
| Stochastic Oscillator | 23.98 | 71.51 |
Price Performance
Historical ComparisonAbout LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.